Theriva Biologics GAAP EPS of -$1.93

* Theriva Biologics press release [https://seekingalpha.com/pr/20195898-theriva-biologics-reports-second-quarter-2025-operational-highlights-and-financial-results] (NYSE:TOVX [https://seekingalpha.com/symbol/TOVX]): Q2 GAAP EPS of -$1.93.
* Cash and cash equivalents of $12.1 million as of June 30, 2025, expected cash runway into Q1 2026

MORE ON THERIVA BIOLOGICS

* Seeking Alpha’s Quant Rating on Theriva Biologics [https://seekingalpha.com/symbol/TOVX/ratings/quant-ratings]
* Historical earnings data for Theriva Biologics [https://seekingalpha.com/symbol/TOVX/earnings]
* Financial information for Theriva Biologics [https://seekingalpha.com/symbol/TOVX/income-statement]